Newsroom | 3545 results
Sorted by: Latest
-
Unicharm Releases "Integrated Report 2026" and "Sustainability Report 2026" Highlighting Transformation of Growth Structure
TOKYO--(BUSINESS WIRE)--Unicharm Corporation (TOKYO: 8113) is pleased to announce the publication of its "Integrated Report 2026" and "Sustainability Report 2026," which summarize the company's continuous efforts toward sustainable corporate value creation, for all of our stakeholders. In 2026, marking its 65th anniversary, Unicharm launched its 13th Medium-Term Management Plan, "Project Renaissance," a five-year plan spanning through 2030. In these reports, under its unique management model "M...
-
Carter’s, Inc. Announces Quarterly Dividend
ATLANTA--(BUSINESS WIRE)--The Board of Directors of Carter’s, Inc. (NYSE:CRI) today declared a quarterly dividend of $0.25 per share, payable on September 25, 2026, to shareholders of record at the close of business on September 1, 2026. Future declarations of quarterly dividends and the establishment of future record and payment dates will be at the discretion of the Company’s Board of Directors based on a number of factors, including business conditions, the Company’s future financial perform...
-
iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual Symposium
PHILADELPHIA--(BUSINESS WIRE)--iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM...
-
Reproductive Endocrinologist Dr. Kelly M. Chacón Joins RMA San Diego, Expanding Fertility Care in the Region
SAN DIEGO--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and assisted reproduction, announced today that Dr. Kelly M. Chacón, a nationally recognized reproductive endocrinologist and infertility specialist, has joined the RMA San Diego care team. Dr. Chacón is now seeing patients at RMA’s San Diego clinic, located at 4510 Executive Drive, Suite 150. “Patients come to me at one of the most difficult points in their lives, and it is my privilege to walk with them toward one o...
-
Save Now. Earn More for What's Next. Kohl's Back-to-School Savings Event Starts Aug. 19
MENOMONEE FALLS, Wis.--(BUSINESS WIRE)--The final weeks of back-to-school shopping are here, and Kohl's (NYSE: KSS) is bringing together some of the season's biggest savings in one event. During Kohl's Back-to-School Sale, Aug. 19–23, customers can save on back-to-school must-haves across apparel, shoes, backpacks, beauty, and dorm essentials—and earn Kohl's Cash® to put toward the next items on their list. Save Now. Earn More for Later. From classroom basics to college move-in, customers can s...
-
Cambia Health Foundation Awards More Than $500,000 to Strengthen Integrated Primary Care
PORTLAND, Ore.--(BUSINESS WIRE)--The U.S. healthcare system focuses on treating disease but too often fails to address factors like housing instability, food insecurity and lack of behavioral healthcare access that are also fundamental to a person's overall health and well-being. Cambia Health Foundation is committed to bridging that divide, announcing more than $500,000 in grants to expand and support integrated primary care teams across Idaho, Oregon, Utah and Washington. “Everyone deserves t...
-
First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio
PENSACOLA, Fla.--(BUSINESS WIRE)--Reckitt Benckiser (LON: RKT) subsidiary, Mead Johnson is facing the first bellwether today as part of a multidistrict litigation (MDL) in the US District Court for the Northern District of Illinois over its infant formula Enfamil being linked to necrotizing enterocolitis (NEC) in a premature infant. Inman v. Mead Johnson & Company, LLC, et al. is the first case against Mead Johnson in the MDL to proceed to trial. NEC is a severe intestinal disease that can...
-
Owlet Announces Second Quarter 2026 Financial Results
LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2026. Owlet’s President, Chief Executive Officer, and Co-Founder, Kurt Workman, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, August 11, 2026, at 4:30 p.m. ET. Q2 2026 Financial Highlights: Record Q2 Reve...
-
TherapeuticsMD Announces Second Quarter 2026 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended June 30, 2026. Second Quarter 2026 Financial Results Net Income from Continuing Operations Net income from continuing operations totaled $164 thousand, compared to net income of $545 thousand for the second quarter of 2025. License Revenues from Continuing Operations The Com...
-
AngelEye Health Earns Fifth Consecutive Inc. 5000 Recognition
NASHVILLE, Tenn.--(BUSINESS WIRE)--AngelEye Health earns a spot on the 2026 Inc. 5000, rising 32% nationally and strengthening its leadership in neonatal and pediatric digital care....